← Back to Search

Nonsteroidal Anti-inflammatory Drug (NSAID)

Ibuprofen + Dexamethasone for Lower Back Pain

Phase 4
Recruiting
Led By Eddie Irizarry, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pain duration <2 week
Age 18-70 Enrollment will be limited to adults <70 years because of the increased risk of adverse medication effects in older adults.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 days (48 hours)
Awards & highlights

Study Summary

This trial studies how well a 2-day dose of dexamethasone and ibuprofen help patients with acute low back pain. Patients will get a low back pain education session too.

Who is the study for?
This trial is for adults aged 18-70 with acute radicular low back pain, which hasn't lasted more than two weeks and radiates from the lower back to the leg. Participants should have a significant level of disability due to their pain but can't have had frequent back pain in the past three months or direct trauma recently. They must not be pregnant, suffer from chronic pain syndromes, or have conditions that make ibuprofen or dexamethasone risky.Check my eligibility
What is being tested?
The study tests if adding dexamethasone to standard care (ibuprofen and education on low back pain) helps improve outcomes for acute radicular low back pain when given during an emergency department visit. Patients are randomly assigned to receive either dexamethasone or a placebo alongside ibuprofen, without knowing which one they're getting.See study design
What are the potential side effects?
Possible side effects include stomach issues like ulcers and bleeding for ibuprofen; while dexamethasone may cause mood changes, increased blood sugar levels, insomnia, and weakened immunity among others.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My pain has lasted less than 2 weeks.
Select...
I am between 18 and 70 years old.
Select...
My back pain severely affects my daily activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 days (48 hours)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 days (48 hours) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Roland Morris Disability Questionnaire (RMDQ) score
Secondary outcome measures
Absolute Roland Morris Disability Questionnaire (RMDQ) score
Analgesic or LBP medication within the previous 24 hours
Frequency of Radicular LBP
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Ibuprofen + dexamethasone + educational interventionExperimental Treatment3 Interventions
Ibuprofen 400 mg PO every 8 hours as needed for 7 days + dexamethasone 16 mg PO for day 1 and day 2. Research personnel will provide each participant with a 15-minute educational intervention.
Group II: Ibuprofen + placebo + educational interventionPlacebo Group2 Interventions
Ibuprofen 400 mg PO every 8 hours as needed for 7 days + placebo PO for day 1 and day 2. Research personnel will provide each participant with a 15-minute educational intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational Intervention
2013
N/A
~7120
Dexamethasone Oral
2020
N/A
~14110
Ibuprofen 400 mg
2021
Completed Phase 4
~1930

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor
446 Previous Clinical Trials
582,642 Total Patients Enrolled
Eddie Irizarry, MDPrincipal InvestigatorMontefiore Medical Center
1 Previous Clinical Trials
198 Total Patients Enrolled

Media Library

Ibuprofen 400 mg (Nonsteroidal Anti-inflammatory Drug (NSAID)) Clinical Trial Eligibility Overview. Trial Name: NCT05721027 — Phase 4
Lower Back Pain Research Study Groups: Ibuprofen + dexamethasone + educational intervention, Ibuprofen + placebo + educational intervention
Lower Back Pain Clinical Trial 2023: Ibuprofen 400 mg Highlights & Side Effects. Trial Name: NCT05721027 — Phase 4
Ibuprofen 400 mg (Nonsteroidal Anti-inflammatory Drug (NSAID)) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05721027 — Phase 4
~69 spots leftby Jul 2025